CesiKids Mobile-Based Psychological Resilience Program
CesiKids Mobile-Based Psychological Resilience Program: The CesiKids Program will be a nurse-led, AI-supported mobile intervention to enhance psychological resilience in adolescents diagnosed with cancer. Grounded in Bronfenbrenner's Bioecological Theory, it will address interactions between adolescents and their family, peers, and clinical environments. Developed through a co-design process with nurses, recovered adolescents, and parents, the program will include AI-driven adaptive feedback and emotional support features. Delivered over four weeks with structured digital sessions, CesiKids will promote emotional regulation, coping, and resilience through interactive storytelling, reflection, and personalized guidance. This integrative model will combine ecological principles, AI personalization, and participatory design to create an innovative psychosocial care approach for hospitalized adolescents with cancer.
Study summary
This study will develop and evaluate a mobile-based co-design intervention (CesiKids) to enhance psychosocial resilience in hospitalized adolescents aged 12-18 diagnosed with cancer. The program will be created using Bronfenbrenner's Ecological Systems Theory and designed in collaboration with nurses, recovered adolescents, and parents. A randomized controlled design will be used. The intervention group will participate in a four-week structured program, while the control group will receive standard care. Psychosocial resilience and coping outcomes will be assessed at baseline, post-intervention, and follow-up. This research aims to offer an evidence-based, scalable model to support resilience among adolescents with cancer in clinical settings.
Eligibility
Sex
ALL
Min age
12 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
* Parents have provided informed consent after receiving information,
* The child has given assent to participate after being informed,
* The child is between 12 and 18 years of age,
* The child has been diagnosed with cancer and is currently receiving inpatient treatment,
* The child is undergoing chemotherapy and/or radiotherapy,
* The child is able to use a computer and/or smartphone,
* The child can understand and speak Turkish.
Exclusion Criteria:
* Receiving hematopoietic stem cell transplantation treatment,
* Having developed a relapse after remission,
* Experiencing communication difficulties (e.g., intellectual disability, visual impairment, etc.),
* Having a psychiatric diagnosis made by a psychiatrist,
* Having experienced a significant life event affecting psychological well-being within the past four weeks (e.g., death, divorce, etc.).
Primary outcome measure(s)
Child and Youth Resilience Measure (CYRM-R) — Baseline (prior to intervention), immediately post-intervention (within 1 week after completion), 3 months post-intervention, and 6 months post-intervention The Child and Youth Resilience Measure-Revised (CYRM-R) is a multidimensional scale based on the socio-ecological model to assess resilience. The 28-item original version was developed by Liebenberg, Ungar, and Van de Vijver through the International Resilience Project. Later, Liebenberg, Ungar, and LeBlanc created a 12-item short form with three subscales: individual, relational, and contextual resilience. Factor loadings ranged from .39-.88, and Cronbach's alpha was .84. Items are rated on a five-point Likert scale (1-5), with higher scores indicating greater resilience. The Turkish adaptation by Arslan showed strong reliability (α = .91; item-total correlations = .45-.79). In this study, the CYRM-R will assess changes in adolescents' resilience after the CesiKids program.
Trial sites (1)
Facility
City
Region
Status
Ankara University Faculty of Medicine Cebeci Research and Practice Hospital
Ankara
Ankara
More Eskisehir Osmangazi University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.